Skip to main content
. 2020 Oct 9;41(12):1671–1681. doi: 10.1093/carcin/bgaa105

Figure 4.

Figure 4.

Five-year disease-specific survival in each pStage stratified by CD8+ TILs and color coded into distinct subgroups with similar survival and disease-specific survival curves according to pStage and to a proposed TNM-Immune cell score for all patients (A–C), the LUSC subgroup (D–F) and the LUAD subgroup (G–I).